A new report from the Government Accountability Office outlines the safety concerns connected with U.S. government oversight of foreign medications and medicinal components. It’s a situation that U.S. Sen. Tom Harkin, chairman of the Health, Education, Labor and Pensions Committee, says Congress needs to address.
The American Independent has previously reported on the growing corporatization of the incipient medical marijuana industry at a time when medical marijuana dispensaries scrabble to hold on to their businesses in the face of a multi-pronged federal crackdown. But there are signs afoot that it just may become More…
In early August, an obscure measure called Proposition C — which prohibits the government from mandating the purchase of health insurance — passed overwhelmingly in a Missouri referendum and soon became national news. While seen by many legal scholars as a largely symbolic act of defiance, the new statute More…
The Associated Press reports that two additional nonprofits that support conservative causes — Americans for Job Security and The 60 Plus Association — have joined the election spending fray in a big way, buying $5 million in advertisements attacking Democrats in House races in swing districts across the country:
First of all, take all the weeks of merger negotiations and throw them out the window: It’s looking more and more like the only way the Democrats can pass health care reform — and they must pass health care reform — in the wake of yesterday’s election in More…
Among the chief discrepancies between the House and Senate health reform proposals is a provision of the House bill that would allow states to negotiate directly with pharmaceutical companies for lower drug prices on behalf of their lowest income seniors — those eligible for both Medicare and Medicaid. House leaders, More…
In a big win for the pharmaceutical industry, the Senate on Tuesday killed legislation that would have made it easier for Americans to buy their prescription drugs from abroad, where prices are generally much cheaper.
The count was 51 to 48, nine shy of the supporters needed to More…
Via The Wall Street Journal, here’s the inane argument being tried by Merck, the pharmaceutical giant that defended itself before the Supreme Court this week against investors suing over the company’s failure to concede the risks of Vioxx before 2004, when the popular arthritis drug was More…
In 2007, after passing legislation to rein in the schmoozy junkets that allowed lobbyists to buy face time with lawmakers, congressional leaders from all political walks applauded their effort as a long stride toward limiting the influence of moneyed interests over Washington policymakers.
“We have promised the highest ethical standard,” More…
rss